Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Two U.S. luxury houses and the FTC are set to battle in court to reach a final decision that will change the market.
The Federal Trade Commission published a new report about the data collection policies of social media platforms and video ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
A decision on the Federal Trade Commission’s noncompete ban came down to the wire. A federal judge in Texas recently blocked the FTC’s noncompete ban, which was approved by the commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback